Home » Education » Dr. Uldrick on Rituximab Plus Liposomal Doxorubicin in HIV-Infected Patients With KSHV-MCD

Dr. Uldrick on Rituximab Plus Liposomal Doxorubicin in HIV-Infected Patients With KSHV-MCD

Written By OncLive on Thursday, Jun 18, 2015 | 04:04 PM

 
Thomas S. Uldrick, MD, staff clinician, HIV and AIDS Malignancy Branch, Center for Cancer Research at the National Institutes of Health, discusses long-term data from a study examining rituximab plus liposomal doxorubicin in HIV-infected patients with Kaposi sarcoma herpes virus-associated multicentric Castleman disease (KSHV-MCD).

Disclaimer:
All images, musics and videos copyright are belong to their respective owners. We just put embed contents from Youtube.com and do not host any content in our server. These content(s) may be protected by copyright law or other laws regarding intellectual property of the United States or other countries. Downloading file(s) on this site is just for review purpose. If you love the song, please support the artists by buying the original CD/Cassette or buying the song from iTunes.